Hosted by the European Society for Medical Oncology (ESMO)

Participation is FREE

MAP 2021 will start with a pre-Congress educational workshop, developed specifically for young investigators, on Thursday 7 October. The main Congress programme will continue on Friday 8 and Saturday 9 October 2021.

International key opinion leaders will discuss the full range of topics in the field of molecular analysis for precision oncology:

• Molecular characterisation
• Clonal evolution
• Metastases (cancer cell intrinsic)
• Microenvironment in metastasis
• Myeloid targets for immunotherapy
• Transcription and translation inhibitors in cancer treatment
• Lung cancer
• New technologies for therapeutic targeting
• Early detection

Learning Objectives

• Provide up to date information on the molecular characterisation and clonal evolution of solid tumours
• Acquire a better understanding of mechanisms driving tumour expansion, metastatic dissemination and the complex cross talk between malignancy, microenvironment and host
• Follow-up on insights in immuno-oncology and new targetable regulators (myeloid cells, checkpoints, stroma, microbiota)
• Learn about therapeutic developments related to new targets and effectors (gene editing, CAR-T cells, antibody-drug conjugates, epigenetic regulators)

Abstracts

• Submission deadline: 28 July 2021
• Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the MAP 2021 Virtual Congress. It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis. 

Further details on the event's website: https://www.esmo.org/meetings/map-2021-virtual/programme